EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 16 rujna 2024. Database contains 4691 unique substances/entries.

Filter the list

Prikazano 601 - 700 od 4.691 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC
trioctyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
triphenyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
tripropyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex BLUE TZ 4312	423-770-3	-	Eye Dam. 1
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III)	423-100-1	-	Eye Dam. 1
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 TURQUOISE 10 40 518	411-430-7	-	Eye Dam. 1; Skin Sens. 1
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) RED JB 747	418-220-4	-	Skin Sens. 1
Trypanosoma brucei brucei	-	-		P Parasites
Trypanosoma brucei gambiense	-	-		P Parasites
Trypanosoma brucei rhodesiense	-	-		P Parasites
Trypanosoma cruzi	-	-		P Parasites
uranium compounds with the exception of those specified elsewhere in this Annex show/hide Difluorodioxouranium EC / List no: 236-898-8 \| CAS no: 13536-84-0 Zinc bis(acetato-O)dioxouranate EC / List no: 233-390-8 \| CAS no: 10138-94-0 Triuranium octaoxide EC / List no: 215-702-4 \| CAS no: 1344-59-8 Disodium uranium tetraoxide EC / List no: 236-846-4 \| CAS no: 13510-99-1 Nitric acid, uranium(6+) salt EC / List no: - \| CAS no: 20820-60-4 Calcium diuranium heptaoxide EC / List no: 237-428-4 \| CAS no: 13780-21-7 Nickel triuranium decaoxide EC / List no: 239-876-6 \| CAS no: 15780-33-3 Bis(2-ethylhexanoato-O)dioxouranium EC / List no: 267-849-9 \| CAS no: 67939-77-9 Bis(acetato-O)dioxouranium EC / List no: 208-767-5 \| CAS no: 541-09-3 Barium uranium oxide EC / List no: - \| CAS no: 10380-31-1 Uranium tetraiodide EC / List no: 236-735-0 \| CAS no: 13470-22-9 Uranium hexafluoride EC / List no: 232-028-6 \| CAS no: 7783-81-5 Uranium pentafluoride EC / List no: 237-405-9 \| CAS no: 13775-07-0 Uranium nitrate EC / List no: - \| CAS no: 13826-82-9 Dipotassium heptaoxodiuranate EC / List no: 232-217-3 \| CAS no: 7790-63-8 Dioxobis(pentane-2,4-dionato-O,O')uranium EC / List no: 241-951-3 \| CAS no: 18039-69-5 Resin acids and Rosin acids, uranyl salts EC / List no: 273-325-0 \| CAS no: 68956-97-8 Sodium tris(benzeneacetato-O)dioxouranate(1-) EC / List no: 309-040-6 \| CAS no: 99800-13-2 Diammonium diuranium heptaoxide EC / List no: 231-986-2 \| CAS no: 7783-22-4 Dipotassium uranyl bis(sulphate), of uranium depleted in uranium-235 EC / List no: 262-284-4 \| CAS no: 60542-74-7 Titanate(4-), oxobis[phosphato(3-)]-, barium (1:2), uranium-doped EC / List no: 309-550-9 \| CAS no: 100403-10-9 Hydrogen dioxo[phosphato(3-)-O,O']uranate(1-) EC / List no: 242-306-9 \| CAS no: 18433-48-2 Bis(nitrato-O)dioxouranium EC / List no: 233-266-3 \| CAS no: 10102-06-4 Uranium fluoride (U2F9) EC / List no: - \| CAS no: 12134-48-4 [oxalato(2-)-O,O']dioxouranium EC / List no: 217-986-5 \| CAS no: 2031-89-2 Uranium tetraboride EC / List no: 234-520-6 \| CAS no: 12007-84-0 Uranium tetrachloride EC / List no: 233-057-7 \| CAS no: 10026-10-5 Disodium heptaoxodiuranate, of uranium depleted in uranium-235 EC / List no: 237-286-3 \| CAS no: 13721-34-1 Uranium disilicide EC / List no: 234-906-4 \| CAS no: 12039-85-9 Uranium tetrabromide EC / List no: 236-734-5 \| CAS no: 13470-20-7 Bis(formato-O)dioxouranium EC / List no: 241-063-6 \| CAS no: 16984-59-1 Calcines, uranium ore-conc. Calcined precipitates of ammonium, magnesium or sodium uranates obtained from natural uranium ores. EC / List no: 297-819-0 \| CAS no: 93763-02-1 Uranium trifluoride EC / List no: 237-404-3 \| CAS no: 13775-06-9 Sodium uranyl triacetate, of uranium depleted in uranium-235 EC / List no: 241-714-4 \| CAS no: 17712-38-8 Uranium tetrafluoride EC / List no: 233-170-1 \| CAS no: 10049-14-6 Triuranium tetraphosphide EC / List no: 234-871-5 \| CAS no: 12037-84-2 Uranium trioxide EC / List no: 215-701-9 \| CAS no: 1344-58-7 Magnesium uranium(4+) hexaacetate EC / List no: 243-905-8 \| CAS no: 20596-93-4 Uranium carbide (UC2) EC / List no: - \| CAS no: 12071-33-9 Dichlorodioxouranium EC / List no: 232-246-1 \| CAS no: 7791-26-6 Bis(nitrato-O,O')dioxouranium EC / List no: 253-053-9 \| CAS no: 36478-76-9 Nickel uranyl tetraacetate, of uranium depleted in uranium-235 EC / List no: 275-994-4 \| CAS no: 71767-12-9 Uranium diboride EC / List no: 234-508-0 \| CAS no: 12007-36-2 Uranium triiodide EC / List no: 237-406-4 \| CAS no: 13775-18-3 Uranium hydride (UH3) EC / List no: - \| CAS no: 13598-56-6 Uranium diselenide EC / List no: 235-245-4 \| CAS no: 12138-21-5 Uranium dioxide EC / List no: 215-700-3 \| CAS no: 1344-57-6 Tetraammonium uranyl tricarbonate, of uranium depleted in uranium-235 EC / List no: 241-988-5 \| CAS no: 18077-77-5 Acetic acid, uranium(4+) zinc salt EC / List no: 243-904-2 \| CAS no: 20596-91-2 Uranium hydride EC / List no: 257-346-2 \| CAS no: 51680-55-8 Zinc tetrakis(acetato-O)dioxouranate EC / List no: 251-762-8 \| CAS no: 33959-50-1 Oxobis(pentane-2,4-dionato-O,O')uranium EC / List no: 254-311-3 \| CAS no: 39136-40-8 Uranium ditelluride EC / List no: 235-249-6 \| CAS no: 12138-37-3 Uranium dioxideperoxide EC / List no: 234-852-1 \| CAS no: 12036-71-4 Tetrakis(pentane-2,4-dionato-O,O')uranium EC / List no: 265-498-6 \| CAS no: 65137-03-3 Uranium nitride EC / List no: - \| CAS no: 12058-37-6 polysilicate EC / List no: - \| CAS no: 12427-14-4 Lead uranate pigment EC / List no: 287-565-9 \| CAS no: 85536-79-4 Magnesium diuranium heptaoxide EC / List no: 236-982-4 \| CAS no: 13568-61-1 Uranium EC / List no: 231-170-6 \| CAS no: 7440-61-1 Uranium disulphide EC / List no: 234-884-6 \| CAS no: 12039-14-4 Dioxo[sulphato(2-)-O]uranium EC / List no: 215-240-3 \| CAS no: 1314-64-3	-	-	Acute Tox. 2; STOT RE 2
Vaccinia virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Variant Creutzfeldt-Jakob disease	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Variola (major and minor) virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Venezuelan equine encephalomyelitis	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Vesicular stomatitis virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Vibrio cholerae (including El Tor)	-	-		B Bacteria and similar species
Vibrio parahaemolyticus	-	-		B Bacteria and similar species
Vibrio spp.	-	-		B Bacteria and similar species
Wesselsbron virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
West Nile fever virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Western equine encephalomyelitis	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Whitepox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Wuchereria bancrofti	-	-		P Parasites
Yatapox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yellow fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yersinia enterocolitica	-	-		B Bacteria and similar species
Yersinia pestis	-	-		B Bacteria and similar species
Yersinia pseudotuberculosis	-	-		B Bacteria and similar species
Yersinia spp.	-	-		B Bacteria and similar species
zinc chromates including zinc potassium chromate show/hide Zinc chromate EC / List no: 236-878-9 \| CAS no: 13530-65-9 Potassium hydroxyoctaoxodizincatedichromate(1-) EC / List no: 234-329-8 \| CAS no: 11103-86-9 C.I. Pigment Yellow 36 EC / List no: 609-398-6 \| CAS no: 37300-23-5 Pentazinc chromate octahydroxide EC / List no: 256-418-0 \| CAS no: 49663-84-5 Zinc dichromate EC / List no: 237-843-0 \| CAS no: 14018-95-2	-	-	Carc. 1A; Acute Tox. 4; Skin Sens. 1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex	425-240-7	-	Eye Dam. 1
'amyl nitrite', mixed isomers	203-770-8	110-46-3	Flam. Liq. 2; Acute Tox. 4
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)	430-460-1	133636-82-5	Skin Corr. 1B; Skin Sens. 1
(+/-)-(R,R)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane	606-373-1	197706-50-6	Skin Sens. 1
(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride	432-360-3	105813-13-6	Acute Tox. 4; Skin Sens. 1
(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine BRL 29226	406-030-4	105812-81-5	Acute Tox. 4; Eye Dam. 1
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate	214-619-0	1166-46-7	Carc. 2; Acute Tox. 4; STOT SE 2
(1-hydroxydodecylidene)diphosphonic acid KELCOR; LIPOKEL; SEQUOL	425-230-2	16610-63-2	Skin Corr. 1B
(1R,2S,5R)-2-[(4-chlorophenyl)methyl]-5-propan-2-yl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol	-	115850-69-6	Repr. 1B; Acute Tox. 4; STOT RE 2
(1R,2S,5S)-2-[(4-chlorophenyl)methyl]-5-propan-2-yl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol	-	115937-89-8	Repr. 1B; Acute Tox. 4; STOT RE 2
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptanes dihydrobromide CP-84,203-4; DFX-5S	411-000-9	125224-62-6	Skin Sens. 1
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride	426-200-1	172015-79-1	STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(-3-(diethylammonio)propylamino)1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate BLUE 10 25 964	407-240-9	159604-94-1	Skin Sens. 1
(2,3-dimethylbut-2-yl)-trimethoxysilane	439-360-2	142877-45-0	Skin Irrit. 2; Eye Dam. 1
(2,6-xylyloxy) acetic acid	430-910-7	13335-71-2	Acute Tox. 4; Eye Dam. 1
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone BUTAMINONITRODARONE; SR33581	444-800-1	141645-23-0	Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino) acetamide	-	166900-80-7	Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
(2E)-3-phenylprop-2-enal	604-377-8	14371-10-9	Skin Sens. 1A
(2R)-butan-2-amine	236-232-6	13250-12-9	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane	433-820-6	118058-74-5	Eye Irrit. 2
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole	822-682-6	1417782-03-6	Skin Sens. 1
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid CIN 10094329; SENSIBILISATOR KF 693 PINA; SENSITIZER KF 693 PINA	422-240-9	166596-68-5	Eye Dam. 1; Skin Sens. 1
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide	420-380-5	136465-81-1	Acute Tox. 4; Eye Dam. 1
(3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone	444-350-6	133413-70-4	Eye Irrit. 2
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide PTH-AA	430-230-0	136522-17-3	Acute Tox. 4
(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate(1-) PHOTOAMORCEUR 22074; RHODORSIL PHOTOINITIATOR 2074; TEPBI	422-960-3	178233-72-2	Acute Tox. 4; STOT RE 2
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane SILANEOPHAN	405-020-7	105024-66-6	Repr. 1B
(4aR,8aR)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one	428-690-2	1668-86-6	Acute Tox. 4; Eye Irrit. 2
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine	425-930-8	151213-39-7	Skin Corr. 1B; Acute Tox. 4; STOT RE 2
(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 2691; CARTASOL BRILLANT SCHARLACH K-2GL KONZ.; CARTASOL BRILLANTSCHARLACH K-2GL FLÜSSIG (ZUBEREITUNG); CARTASOL BRILLANTSCHARLACH K-2GL GRANULAT (ZUBEREITUNG); CARTASOL BRILLIANT SCARLET K-2GL; CARTASOL BRILLIANT SCARLET K-2GL CONC.	402-060-7	108225-03-2	Carc. 1B; Eye Dam. 1
(6R-trans)-1-((7-ammonio-2- carboxylato-8-oxo-5-thia-1- azabicyclo-[4.2.0]oct-2-en-3- yl)methyl)pyridinium iodide	423-260-0	100988-63-4	Muta. 2; Skin Sens. 1
(E)-2-butenal; (E)-crotonaldehyde	204-647-1	123-73-9	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal DPP	410-980-5	112704-51-5	Eye Irrit. 2; Skin Sens. 1
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal PYRIDYLACROLEIN	426-330-9	177964-68-0	Eye Irrit. 2; Skin Sens. 1
(E)-3-methyl-5-cyclopentadecen-1-one	429-900-5	101151-17-1	Skin Sens. 1
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol	423-240-1	125474-34-2	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised AOC 1020X	402-370-2	149057-70-5	Flam. Liq. 3; Eye Dam. 1
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride CARTASOL GEEL M-GL CONC.; CARTASOL GELB M-GL FLÜSSIG (ZUBEREITUNG); CARTASOL GELB M-GL KONZ.; CARTASOL YELLOW M-GL CONC.; HM 2580	401-500-5	118658-99-4	Carc. 1B
(N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzenesulfonate TICA 118	422-200-0	178277-55-9	Skin Corr. 1B; Acute Tox. 4
(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %)	-	178961-20-1	Skin Sens. 1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole	430-560-5	180637-89-2	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Skin Sens. 1
(R)-butan-2-ol	238-967-8	14898-79-4	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-780-1	103146-25-4	Acute Tox. 4; Skin Sens. 1
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy} ethyl methyl carbonate; tolpyralate	701-225-3	1101132-67-5	Carc. 2; Repr. 2; STOT RE 2
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide UK-88,861-04	421-810-4	194602-27-2	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid	430-900-2	192725-50-1	Eye Dam. 1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-770-7	128173-52-4	Acute Tox. 4; Skin Sens. 1
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide CZ-AMIDE; PTH-TETRAHYDROAMIDE; TETRAHYDROAMIDE (THA)	414-600-9	149182-72-9	Acute Tox. 4
(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide TRUSOPT INTERMEDIATE, L-686,771	415-030-3	120298-38-6	Skin Sens. 1
(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide BENACTIVE GOLDEN YELLOW CN-GL; C.I. REACTIVE YELLOW 178; KAYACELON REACT GOLDEN YELLOW CN-GL; SOMAZIN GOLDEN YELLOW CN-GL	404-250-5	115099-55-3	Skin Sens. 1
(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid CARTASOL TUERKIS K-ZBL KONC.; CARTASOL TURQUOISE K-JD 2336; CARTASOL TURQUOISE K-JD 2336 CONC.; CARTASOL TURQUOISE K-ZBL CONC.; CARTASOL TÜRKIS K-ZBL FLÜSSIG; CARTASOL TÜRKIS K-ZBL KONZ.; TURQUOISE CARTASOL K-JD 2336 CONC.	401-260-1	118800-27-4	Eye Irrit. 2
(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride	424-740-2	138271-16-6	Acute Tox. 4; Eye Dam. 1
(Z)-1,3-dichloropropene	233-195-8	10061-01-5	Flam. Liq. 3; Acute Tox. 3; Acute Tox. 4; Asp. Tox. 1; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride A-83851	410-780-8	1379676-72-8	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride CLEARFRAC J508B	426-210-6	120086-58-0	Skin Corr. 1B
(Z)-octadec-9-enylamine	204-015-5	112-90-3	Acute Tox. 4; Asp. Tox. 1; STOT SE 3; STOT RE 2; Skin Corr. 1B
(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol POLYSANTOL	411-580-3	107898-54-4	Skin Irrit. 2
(±)-1-methyl-4-(1-methylvinyl)cyclohexene;dipentene; limonene	205-341-0	138-86-3;7705-14-8	Flam. Liq. 3; Skin Irrit. 2; Skin Sens. 1
(±)-1-methyl-4-(1-methylvinyl)cyclohexene;dipentene; limonene	205-341-0	138-86-3;7705-14-8	Flam. Liq. 3; Skin Irrit. 2; Skin Sens. 1
(±)-butan-2-ol;butan-2-ol	201-158-5	15892-23-6;78-92-2	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(±)-butan-2-ol;butan-2-ol	201-158-5	15892-23-6;78-92-2	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine BRL 44742	415-550-0	109887-53-8	Acute Tox. 4; Eye Dam. 1
(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate CG 24-020; FERROCEN-SBF6	407-840-0	100011-37-8	Acute Tox. 4; Eye Dam. 1
(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate CG 26-751	407-880-9	117549-13-0	Acute Tox. 4
1,1',1'-nitrilotripropan-2-ol; triisopropanolamine	204-528-4	122-20-3	Eye Irrit. 2
1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) COMPIMIDE™ 121	405-840-5	110866-35-8	Skin Sens. 1

Prikazano 601 - 700 od 4.691 rezultata.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 16 rujna 2024. Database contains 4691 unique substances/entries.

Footer Nav Items